A Tech Stock with MASSIVE Upside Potential 🚀

The market continued its recent slide on Monday. Large-cap indexes fell, while the Russ2K managed a small advance.

Dow [-0.4%]
S&P 500 [-0.3%]
Nasdaq [-0.2%]
Russell 2K [+0.1%]

Fortunately, futures are pointing higher in early trading. S&P 500 contracts are up by roughly 0.4%.

What to Watch Today:
Today’s earnings & economic schedules are somewhat uneventful. However, the market is hoping to notch a solid gain after back-to-back losing sessions. It’s going to be a short week, with markets closed Friday, so there’s a little bit more riding on each trading session.

A Tech Stock with MASSIVE Upside Potential

This innovative but previously overlooked growth stock has found itself on Wall Street’s radar.

The company is pioneering a revolutionary tech that could disrupt one of the oldest industries known to man.

It’s already secured several patents, and it’s expanding its market potential at a torrid pace.

Technical analysis indicates the stock could be approaching a breakout, so now is the time to check out this up-and-coming growth stock.

Get a Full Briefing Here (Ticker Included) »

McDonald's to Feature Krispy Kreme Doughnuts
McDonald's [MCD] has announced plans to introduce Krispy Kreme [DNUT] doughnuts across its U.S. locations by the end of 2026. This ambitious collaboration will kick off later this year, marking a significant expansion for Krispy Kreme as it aims to more than double its distribution capacity to meet McDonald's needs.

Exclusive Fast-Food Partnership 🤝
Through this deal, McDonald's becomes Krispy Kreme's sole fast-food partner in the U.S., showcasing a strategic alliance between the two giants. The news sent Krispy Kreme shares surging nearly 20% in premarket trading, underscoring investor enthusiasm for this venture.

Distribution Dynamics 🔄
Krispy Kreme's "hub and spoke" distribution model, known for its efficiency, will play a crucial role in this expansion. The company currently supplies doughnuts to 6,800 third-party stores but aims to scale up to cater to McDonald's vast network of about 13,500 restaurants nationwide.

Capacity and Coverage Challenges 💼
CEO Josh Charlesworth shared insights with CNBC, noting that Krispy Kreme can initially serve around 6,000 McDonald's outlets with its current infrastructure. Efforts are underway to extend reach to all McDonald's locations by enhancing production capabilities.

Beyond McDonald's: A Broader Vision 🌐
This partnership also opens doors for Krispy Kreme to venture into grocery and convenience stores seeking national distributors, promising a broader impact on its distribution efficiency and network productivity.

Boosting Production Without the Cost 🏭
Krispy Kreme's strategy to utilize its excess production capacity aligns with this new demand, turning potential overproduction into an opportunity for increased sales and profitability, with McDonald's acting as a catalyst for growth in the "deliver fresh daily" channel.

Krispy Kreme [DNUT] - Last Close: $12.45
The legendary donut maker is soaring after announcing an expansion to its national partnership with McDonald’s [MCD].

Customers will be able to buy Krispy Kreme donuts inside certain McDonald’s restaurants later this year, with a nationwide rollout expected by 2026.

Financial terms weren’t disclosed, but Krispy Kreme is rallying on the news.
DNUT is up 20.3% on nearly 1 million shares traded.

My Take: DNUT is likely to sell a lot more donuts as a result of this deal. Shares have downtrended lately but this could be the catalyst for a breakout higher.

Stoke Therapeutics [STOK] - Last Close: $6.50

New clinical data supporting STK-001 as a treatment for Dravet Syndrome is lifting shares of Stoke Therapeutics in early premarket trading.

A Phase ½a trial showed the drug demonstrated “substantial and sustained reductions in convulsive seize frequency” and “median reductions of 85% at 3 months.”

The drug was also generally well tolerated, and the company plans to meet with regulatory agencies to discuss a clinical path forward.

STOK is up 80.7% on nearly 3 million shares traded.

My Take: STOK looks like it’s in a good spot, and this rally could help it breakthrough a key resistance point at around $8 per share.

OpGen [OPGN] - Last Close: $0.4750

OpGen is rallying after announcing a $3 million acquisition of its preferred stock by experienced private investor David Lazar.

Under the terms of the agreement, Lazar will acquire 3 million shares of Series E Convertible Preferred Stock at a price of $1 per share.

OPGN is up 60.0% on nearly 20 million shares traded.

My Take: David Lazar’s interest in this company could be a promising signal. Eventually, it could lead to a buyout. OPGN could be worth watching.

Check-Cap [CHEK] - Last Close: $1.97

Late Monday, Check-Cap announced its entrance into a business combination agreement with Nobul Al Corp.

Under the terms of the arrangement, the companies will combine into a public company headquartered in Toronto.

The companies are also planning to apply for listing on the NASDAQ and TSX, and both boards have agreed to the transaction.

CHEK is up 37.3% on nearly 7 million shares traded.

My Take: Details are scant on this deal, and CHEK’s chart doesn’t look very promising. Tread lightly here.

Gainers
ABVC Biopharma [ABVC] >> +49.5%
Mesoblast [MESO] >> +31.8%
Garden Stage [GSIW] >> +34.9%

Decliners
NeuBase Therapeutics [NBSE] >> (55.2%)
Apptech [APCX] >> (39.4%)
Murano Global [MRNO] >> (17.0%)

McCormick & Company [MKC] ... AM

TD Synnex [SNX] ... AM

Waterdrop [WDH] ... AM

Movado [MOV] ... AM

Direct Digital [DRCT] ... AM

GameStop [GME] ... PM

Concentrix [CNXC] ... PM

nCino [NCNO] ... PM

Progress Software [PRGS] ... PM

Forge Global Holdings [FRGE] ... PM

Durable-goods orders [Feb] ... 8:30a
Durable-goods minus transportation [Feb] ... 8:30a
S&P Case-Shiller home price index (20 cities) [Jan] ... 9:00a
Consumer confidence [Mar] ... 10:00a